Coronavirus Disease (COVID-19)
Healthcare Provider Information
Healthcare Provider Information
LabCorp currently offers several options for COVID-19 tests that identify if individuals are infected - or may have been infected - with coronavirus. Learn More
COVID-19 IgG antibody test collections (blood draw) are available through LabCorp patient service centers, including LabCorp at Walgreens locations. This type of COVID-19 test is for individuals who think they may have had COVID-19 and do not have symptoms. Note: antibody testing should not be used as the sole basis to diagnose or exclude infection.
LabCorp patient service centers do not collect specimens for the COVID-19 PCR swab test, which is used for individuals who have COVID-19 symptoms or meet the testing criteria established by the CDC.
LabCorp PSCs remain open for non-COVID-19-related testing collection.
For customers of LabCorp's Drug Development business, Covance, please visit www.covance.com.
If you're interested in becoming a LabCorp customer, initiate a new account or request a visit to your office by one of our representatives to discuss our services.
Physicians and other healthcare providers anywhere in the United States can order COVID-19 PCR testing (Test Code 139900) from LabCorp. The test detects the presence of the underlying virus that causes COVID-19 and is for use with patients who meet current guidance for evaluation of infection with COVID-19.
Serology testing is available to check for different types of antibodies developed after exposure to the SARS-CoV-2 virus that causes COVID-19. This type of COVID-19 test is for individuals who think they may have previously had COVID-19 and do not currently have symptoms. Note: antibody testing should not be used as the sole basis to diagnose or exclude infection (Test Code 164055 or Test Code 164068).
* For information on how to request an at-home collection test kit to detect an active COVID-19 infection, go to Pixel by LabCorpTM.
COVID-19 antibody test collections (blood draw) are available through LabCorp patient service centers, including LabCorp at Walgreens locations. This type of COVID-19 test is for individuals who think they may have had COVID-19 and do not have symptoms. Note: antibody testing should not be used as the sole basis to diagnose or exclude infection.
The COVID-19 PCR tests performed by LabCorp are qualitative assays using PCR technology, which LabCorp played a central role in commercializing when PCR was introduced nearly 30 years ago.
Based on current testing volumes for the COVID-19 PCR test we are now able to deliver test results on an average of 1 to 2 days from the specimen pick up. Test results are most typically reported electronically, which generally allows for faster delivery. This timeframe can vary based on demand, the length of time to transport the specimen to LabCorp’s test facilities. LabCorp's antibody testing results are typically reported in 1 to 3 days after specimen pick up.
LabCorp is reporting COVID-19 results to the appropriate public health agency in accordance with applicable requirements; however, healthcare providers may also be required to report positive patients to the appropriate public health agency.
LabCorp’s COVID-19 PCR test has not been FDA cleared or approved, has been authorized by FDA under an Emergency Use Authorization (EUA), and has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. The test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
LabCorp is providing serology testing based on tests from various manufacturers. Such tests have either received an emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) or were released for use under FDA guidance, “Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency - Immediately in Effect Guidance for Clinical Laboratories, Commercial Manufacturers and Food and Drug Administration Staff” that was updated on May 4, 2020. Tests being performed under an EUA have not been FDA cleared or approved and LabCorp has completed independent validation of these tests. In addition, various manufacturers have submitted or will seek EUA for their test.